Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Oct 1;105(10):e146-e147.
doi: 10.1097/TP.0000000000003883.

Anti-SARS-CoV-2 Monoclonal Antibodies in Solid-organ Transplant Patients

Arnaud Del Bello  1   2 , Olivier Marion  1   2   3 , Camille Vellas  4 , Stanislas Faguer  1   3 , Jacques Izopet  2   3   4 , Nassim Kamar  1   2   3
Affiliations
Comment

Anti-SARS-CoV-2 Monoclonal Antibodies in Solid-organ Transplant Patients

Arnaud Del Bello et al. Transplantation. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no funding or conflicts of interest.

Comment on

References

    1. Gottlieb RL, Nirula A, Chen P, et al. . Effect of bamlanivimab as monotherapy or in combination with etesevimab on viral load in patients with mild to moderate COVID-19: a randomized clinical trial. JAMA. 2021;325:632–644. - PMC - PubMed
    1. Weinreich DM, Sivapalasingam S, Norton T, et al. ; Trial Investigators. REGN-COV2, a neutralizing antibody cocktail, in outpatients with COVID-19. N Engl J Med. 2021;384:238–251. - PMC - PubMed
    1. Kumar RN, Wu EL, Stosor V, et al. . Real-world experience of bamlanivimab for COVID-19: a case-control study. Clin Infect Dis. [Epub ahead of print. April 13, 2021]. doi:10.1093/cid/ciab305 - PMC - PubMed
    1. Dhand A, Lobo SA, Wolfe K, et al. . Bamlanivimab for treatment of COVID-19 in solid organ transplant recipients: early single-center experience. Clin Transplant. 2021;35:e14245. - PMC - PubMed
    1. Dhand A, Lobo SA, Wolfe K, et al. . Casirivimab-imdevimab for treatment of COVID-19 in solid organ transplant recipients: an early experience. Transplantation. 2021;105:e68–e69. - PubMed

Substances